Editor’s summary Abstract Supplementary Materials REFERENCES AND NOTES Information & Authors Metrics & Citations Check Access References Figures Tables Media Share Editor’s summary A major challenge with immunotherapies, including those for glioblastoma, is the limited number of tumor-specific targets for the immune system to focus on; other targets may be enriched on tumor cells, but they run the risk of on-target, off-tumor effects. Here, Maich et al.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile